Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Titan Pharmaceuticals Inc. logo

Titan Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

7.16
 
USD
  
-0.22
  
(-2.98%)
Optionable: Yes  Market Cap: 6 M  90-day average vol: 12,013

Previous close: 7.38  Open: 7.0  Bid: 6.85  Ask: 7.37
52 week range    
5.00   
   16.90
Peers   
VNDA / 
MNOV / 
CLDX / 
JNJ / 
NVS / 
DRRX / 
ELTP / 
BDSI / 
Last updated: Friday 29th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BDSI

0 B12.23.7

CLDX

1 B-17.331.4

DRRX

0 B-6.90.723

ELTP

0 B6.90.04085

JNJ

0.0247450 B22.1171.06

MNOV

0 B-10.82.42

NVS

RGEN

11 B94.4201.39

VNDA

1 B25.313.055
Financials

TTNP Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-21.6-1.96-0.9
Basic EPS total3.6-0.9-16.87.5-20.1-23.4-21.6-4.83-0.9
Basic weighted shares outstanding3 M3 M668433.0691466.0706766.0398666.0765233.04 M10 M
BasicDiscontinuousOperations-2.87
Cost of sales-538000.01 M472000.0199000.0
Depreciation-107000.0-353000.0-358000.0-377000.0-417000.0-380000.0
DepreciationAndAmortization-107000.0-353000.0-358000.0-377000.0-417000.0-380000.0
Diluted EPS total3.0-1.2-16.86.0-21.0-23.7-21.6-4.83-0.9
Diluted normalized net income/share-21.6-0.9
Diluted weighted shares outstanding3 M3 M668433.0715300.0707600.0398666.0765233.010 M
DilutedDiscontinuousOperations-21.6
GainOnSaleOfSecurity-134000.0
GeneralAndAdministrativeExpense3 M3 M4 M5 M-293000.0-300000.05 M6 M5 M6 M
Gross operating profit10 M4 M2 M15 M215000.0-538000.0-1 M4 M1 M557000.0
Income before tax10 M-2 M-11 M5 M-14 M-9 M-7 M-7 M-9 M-10 M
Income taxes-213000.0-592000.0-659000.0-32609.0-121000.0-56000.0-220000.0-67000.0-488000.0
Interest income-2 M37000.0-369000.0-887000.0-967000.0-769000.01000.053000.0
MarketingExpense285000.0
MiscOtherSpecialCharges12 M1 M-5 M755000.0564000.07 M4 M713000.0577000.0-24000.0
Net income from total operations10 M-2 M-11 M5 M-14 M-9 M-7 M-7 M-9 M-10 M
NetIncomeCommonStockholders10 M-2 M-11 M5 M-14 M-9 M-7 M-7 M-9 M-10 M
NetIncomeContinuousOperations10 M-2 M-11 M5 M-14 M-9 M-7 M-7 M-9 M-10 M
NetIncomeDiscontinuousOperations-9 M-11 M
NetIncomeExtraordinary-285000.0
NetNonOperatingInterestIncomeExpense-2 M37000.0-369000.0-887000.0-967000.0-769000.01000.053000.0
NonRecurringOperationExpense75000.0
Normalized income-9 M-11 M
Operating income-891000.0-3 M-7 M4 M-15 M-15 M-10 M-7 M-9 M-10 M
Operating income before depreciation (EBITDA)10 M-2 M-11 M6 M-14 M-9 M-7 M-7 M-9 M-10 M
OperatingExpense-11 M-7 M-8 M-11 M-15 M14 M10 M12 M11 M11 M
Other income net-12 M-1 M5 M-755000.0-564000.0-7 M-4 M-713000.0-577000.024000.0
OtherGainLossFromDispositionOfDiscontinuedOperations-11 M
OtherGandA3 M3 M4 M5 M-293000.0-300000.05 M6 M5 M6 M
RentAndLandingFees3 M3 M4 M5 M-293000.0-300000.0-300000.0300000.0
Research & development expense8 M4 M5 M6 M10 M7 M5 M6 M6 M5 M
ResearchExpense8 M4 M5 M6 M10 M7 M5 M6 M6 M5 M
SalariesAndWages-678000.0-543000.0-1 M-1 M-2 M-2 M-572000.07000.02 M947000.0
Selling Gen & administrative expense3 M3 M4 M5 M5 M7 M5 M6 M5 M6 M
SellingAndMarketingExpense5 M7 M12 M
SellingExpense5 M7 M12 M
Special income/charges-75000.0
Total Income available for interest expense (EBIT)10 M-2 M-11 M5 M-14 M-9 M-7 M-7 M-9 M-10 M
Total common shares outstanding89952.0111442.0111443.0117771.0117798.074520.03 M10 M601971.015 M
Total net income10 M-2 M-11 M5 M-14 M-9 M-7 M-7 M-9 M-10 M
Total ordinary shares781503.0781503.0781503.0781503.0781503.0781503.0781503.0781503.0781503.0781503.0
Total revenues10 M4 M2 M15 M215000.01 M1 M5 M2 M557000.0
TotalExpenses-11 M-7 M-8 M-11 M-15 M14 M10 M12 M11 M11 M
TotalRevenue10 M4 M2 M15 M215000.07 M1 M5 M2 M557000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University